Vir Biotechnology’s elebsiran and tobevibart duo hits key phase 3 trial milestone, with 44% of...
Half of long COVID patients see significant improvement within three years, with over a quarter...
New study reveals ceftobiprole’s nearly full effectiveness against MRSA in the first US surveillance results...
Cefiderocol exhibits improved in vitro activity against multidrug-resistant Gram-negative pathogens at IDWeek 2026, with MICs...
Black Americans face double multiple myeloma risk, experts say. Explore the disparity in incidence and...
New treatments for myelofibrosis and anemia may improve symptoms and quality of life for patients.
New dual-imaging catheter assesses heart attack risk by detecting plaque buildup in arteries, potentially improving...
New research reveals risk-taking behavior predicts heavier drinking before alcohol use disorder worsens, overturning long-held...
People who are marginalized or lack access to a primary care provider face a higher...
New research reveals prenatal depression therapy shapes infant brain growth and emotional responses, showing the...